Logotype for SOPHiA GENETICS SA

SOPHiA GENETICS (SOPH) investor relations material

SOPHiA GENETICS Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for SOPHiA GENETICS SA
Q2 2025 earnings summary5 Aug, 2025

Executive summary

  • Q2 2025 revenue grew 16% year-over-year to $18.3M, driven by new business, advanced applications, and strong global expansion.

  • Signed a record 35 new customers in Q2, totaling 63 new customers year-to-date, and implemented 18 new customers during the quarter.

  • Announced the largest contract in company history: a multi-year AI partnership with AstraZeneca focused on breast cancer predictive modeling and real-world evidence.

  • Cash burn reduced to $8.7M, a 35% year-over-year improvement, and adjusted gross margin rose to 74.4%.

  • AI-powered platform analyzed over 350,000 patients in 2024, serving 800+ institutions in 70+ countries.

Financial highlights

  • Q2 2025 revenue was $18.3M, up from $15.8M in Q2 2024, with 16% year-over-year growth.

  • Adjusted gross margin reached 74.4% in Q2 2025, up 120bps year-over-year.

  • Adjusted EBITDA loss expected between $35M and $39M in 2025, improving from $40.2M in 2024.

  • Cash and equivalents at quarter-end were $94.8M, bolstered by a $35M debt drawdown.

  • Platform analysis volume reached 95,000 in Q2 2025, up 9% year-over-year.

Outlook and guidance

  • Reaffirmed full-year 2025 revenue guidance of $72M–$76M (10%–17% growth) and adjusted EBITDA loss guidance of $35M–$39M.

  • Q4 expected to be the strongest quarter; AstraZeneca revenue recognition to begin in Q4 and continue into 2026.

  • Targeting adjusted EBITDA breakeven by 2026 and positive adjusted EBITDA in 2027.

  • Adjusted gross margin anticipated to expand slightly in 2025.

  • Approximately 60% of incremental revenue expected to flow through to EBITDA.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next SOPHiA GENETICS earnings date

Logotype for SOPHiA GENETICS SA
Q3 20254 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next SOPHiA GENETICS earnings date

Logotype for SOPHiA GENETICS SA
Q3 20254 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

SOPHiA GENETICS SA is a health technology company that provides a cloud-based analytics platform for data-driven medicine. Its solutions support genomic and radiomic data interpretation for clinical and research purposes, primarily in oncology, hereditary disorders, and infectious diseases. The company serves hospitals, laboratories, and pharmaceutical companies. It is headquartered in Saint-Sulpice, Switzerland, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage